Hatemi, G., Tukek, N. B., Esatoglu, S. N., Ozguler, Y., Taflan, S. S., Uygunoglu, U., . . . Hamuryudan, V. (2023). Infliximab for vascular involvement in Behçet's syndrome. Clinical immunology (Orlando, Fla.), 253, 109682. https://doi.org/10.1016/j.clim.2023.109682
Chicago ZitierstilHatemi, Gulen, et al. "Infliximab for Vascular Involvement in Behçet's Syndrome." Clinical Immunology (Orlando, Fla.) 253 (2023): 109682. https://dx.doi.org/10.1016/j.clim.2023.109682.
MLA ZitierstilHatemi, Gulen, et al. "Infliximab for Vascular Involvement in Behçet's Syndrome." Clinical Immunology (Orlando, Fla.), vol. 253, 2023, p. 109682.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.